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Introduction: We examined the role of macrophage inﬂamma-
tory protein (MIP)-3alpha on oral cavity squamous cell carcinoma
(OSCC) and whether it was involved in modulating OSCC cell
functions.
Methods: The study population was comprised of 102 patients
with OSCC. MIP-3alpha levels in tissues were examined by immuno-
histochemistry and quantitative real-time RT-PCR. Effects of MIP-
3alpha on OSCC cell function were investigated by cell proliferation
assays, trans-well migration/invasion assays, and RNA interference.
Results: We found that MIP-3alpha was overexpressed in OSCC
tumor cells. MIP-3alpha expression was signiﬁcantly higher in tumor
cells versus normal epithelial cells, as determined by both quantita-
tive real-time RT-PCR and immunohistochemistry. Overexpression
of MIP-3alpha was signiﬁcantly correlated with positive pN status
(P = 0.036). Nevertheless, there were no correlations related to pa-
tient age, pT status, overall pathological stage, cell differentiation,
or perineural invasion. The long-term disease-speciﬁc survival for
patient subgroups stratiﬁed by the absence or presence of MIP-3al-
pha overexpression was 70.9% vs. 54.7% (P = 0.041). Multivariate
analysis indicated that MIP-3alpha overexpression had a signiﬁ-
cantly lower disease-speciﬁc survival (hazard ratio: 2.158;
P = 0.037). Additionally, in vitro suppression of MIP-3alpha expres-
sion in OECM-1 cells using speciﬁc interfering RNAs attenuated cell
migration and invasiveness.
Discussion: These ﬁndings suggest that MIP-3alpha overexpres-
sion in OSCC is associated with a poorer prognosis for patient sur-
vival and contributes to tumor metastasis.
doi:10.1016/j.oraloncology.2011.06.165
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Introduction: MDM2 is a negative regulator of the p53 tumor
suppressor protein. The presence of a variety of MDM2 splice vari-
ants have been reported in many different types of tumor and some
have been shown to be associated with patient prognosis.
Materials and methods: In this study, we demonstrated the
occurrence of MDM2 splice variants in OSCC tissues. RNA was ex-
tracted from 45 OSCC tissues and 17 normal oral mucosa tissues
and reverse transcribed into cDNA. Nested PCR was performed to
amplify the MDM2 transcripts and the PCR amplicons were cloned
into cloning vector pTZ57R/T and sequenced.
Results: We demonstrated that 37/45 OSCC and 14/17 normal
oral mucosa tissues contained MDM2 splice variants and a total of
34 transcript variants were found. Comparing with the reported
splice variants in GenBank, four known variants, MDM2B, MDM2C,
MDM2-EU2 and MDM2-PM2 were found in tumor samples with
MDM2B being the most common variants found in our samples.
None of these known variants were found in normal oral mucosa
tissues. The other 30 transcript variants were novel, where 3 of
these were present in both tumor and normal tissues, 23 were found
only in tumor tissues and 4 were exclusive to normal oral mucosa
tissue.
Discussion: The common loss among the variants was sequences
coding for the p53 binding domain, acidic domain, nuclear localiza-
tion and nuclear export domains. In general, all 30 novel transcript
variants were aberrantly spliced, however, interestingly, 9/23 aber-
rantly spliced variants in OSCC codes for an in-frame putative pro-
tein, suggesting that despite the aberrant splicing, these transcripts
may still result in a functional protein and therefore further work
to study how these splice variants affect MDM2 function directly
or how they may affect other binding partners is needed.
doi:10.1016/j.oraloncology.2011.06.166
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Introduction: Tongue and cheek cancer have different behaviors.
In order to understand these behaviors, there is a need to look into
the chromosomal alterations and gene pathways that maybe associ-
ated with oral cancer at these sites. Therefore, the objective of this
study is to determine the differences in chromosomal aberrations
and gene pathways involved in tongue and cheek cancer using high
resolution array CGH.
Methods: A genome wide screening with array CGH (SurePrint
G3 CGH 1x1M microarray) was performed using gDNA from 20 snap
frozen fresh tissues consisting of 12 tongue and 8 cheek oral squa-
mous cell carcinomas (samples from the Malaysian Oral Cancer Data
and Tumour Bank System [MOCDTBS] coordinated by OCRCC-UM).
Cytosure Software was used to detect the chromosomal aberrations
and candidate genes related to the selected regions. Pathway analy-
sis was done using MetaCore™software for selected genes.
Results: The mean number of chromosomal aberrations per tu-
mour for tongue cancer (22 ± 24.97) was higher than cheek cancer
(8.38 ± 11.98). The most common ampliﬁed regions in tongue can-
cers were 8q24.22 (33.33%), 8q24.3 (33.33%), 11q13.1 (33.33%),
11q13.2 (33.33%), 12q13.13 (33.33%), 14q32.33 (33.33%) and for
cheek cancer the most common ampliﬁed region was 22q12.3
(25%). For the deleted regions, the most common for tongue cancer
were 2q21.1 (16.67%), 6q21 (16.67%) and for cheek cancer were
2q22.1 (25%), 7q35 (25%), 19q13.33 (25%). The most signiﬁcant path-
way based on p < 0.001 involved in tongue cancer is cell adhesion
ECM remodeling pathway Among the genes involved in ampliﬁed re-
gion, were EGFR, MMP1, MMP10, MMP12, MMP3, MMP7 and MMP9.
For cheek cancer, the cancer associated signiﬁcant pathway was
apoptosis and survival (the role of CDK5 in neuronal death and sur-
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vival). An oncogene located at 8p12 was identiﬁed in this pathway is
NRG1.
Discussion: This study showed a different pattern of chromo-
somal aberrations in tongue and cheek cancer with different signif-
icant gene pathways. Tongue cancer behaves more aggressively than
cheek cancer which may be due to the involvement of ECM remod-
eling pathway, where MMP family which are the proteolytic enzyme
that degrade various component in the extracellular matrix would
favor invasion and metastasis.
Acknowledgment: Grant of UMRG085/09HTM and PS017/
2010A.
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Purpose: OCSCC is associated with high rates of recurrence and
mortality. Although several well-known markers correlated with
poor/metastasis prognosis in OCSCC patients was reported, the
molecular mechanisms of OCSCC development are still not clear.
Here, we explored TSG101 and its-elicited signaling pathway partic-
ipates in the metastatic progression of OCSCC.
Methods: The semi-quantitative-RT-PCR/Q-RT-PCR/Western
blot/IHC approaches were used to evaluate the mRNA/protein
expressions of TSG101 in paired OCSCC specimens. Immunohisto-
chemical staining of TSG101 expression with clinic-patholgic charac-
teristics was examined using univariate and multivariate analyses.
Human oral cancer cell lines with overexpressing-TSG101 or
TSG101-mediated siRNAs were generated by transfection. Transwell
chamber-, Western blot-, pharmacological-inhibitor-, and immuno-
histochemical- assays were done to evaluate the signaling pathways
that were involved.
Results: We created a bioinformatics scheme consisting of inte-
grating two gene expression proﬁle datasets, including un-pairwise
OCSCC, and secondary metastatic tumors vs. benign tumors. Among
the novel targets identiﬁed, TSG101 was down-regulated in OCSCC
tissues and is associated with cancer metastasis. Furthermore, we
employed two co-expression strategies to identify in which pathway
TSG101 was involved. By semi-quantitative-RT-PCR/Q-RT-PCR/Wes-
tern blot/IHC approaches, we found that TSG101 is not only an indi-
cator of poor survival, but also exhibits negative correlations with
FLJ10540 expression in OCSCC specimens. In vitro study, TSG101-
overexpressing transfectants could inhibit the motility of cells via
suppression FLJ10540/p-AKT expression. Conversely, the motility of
oral cancer cells could be increased by knock-down endogenous
TSG101. These data indicated that TSG101 prevents oral cancer
metastasis via FLJ10540/AKT pathway.
Conclusions: These ﬁnding suggested that TSG101 is not only an
important prognostic factor but also a new therapeutic target in the
FLJ10540/AKT pathway for OCSCC treatment.
doi:10.1016/j.oraloncology.2011.06.168
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Introduction: Oral cancer is a debilitating disease and the sur-
vival rates for these patients have not improved over the past dec-
ades. Tobacco smoking is one of the most common risk factor
associated with oral cancer.
Objectives: To explore and identify differential genes expression
associated with tobacco smoking.
Methodology: Next generation sequencing using the Illumina
Genome Analyzer was done to sequence ﬁve fresh frozen oral cancer
tissue samples from smoking patients, two of which were former
smoker and an additional 8 samples consisting of normal oral muco-
sal tissues from the alveolar mucosa of non-cancer patients where 4
were smokers and another 4 were non-smokers. The tissues and so-
cio-demographic information were obtained from the Malaysian
Oral Cancer Data and Tumour Bank System (MOCDTBS) at the Oral
Cancer Research and Coordinating Centre (OCRCC). High quality poly
A+ RNA was extracted from macrodissected tumour and normal epi-
thelial tissue to obtain >70%. Validation of second generation
sequencing was done using commercial and custom microarrays.
Principle component analysis (PCA) was applied to the sequenced
generated data.
Results and discussion: PCA showed distinct clusters separating
groups of current and former smokers. The former smoker who
ceased smoking >25 years clustered closely with normal non-smoker
suggesting expression levels of some of the genes related to tobacco
smoking could return to levels similar to never smokers upon cessa-
tion of smoking. When comparing differential gene expression be-
tween tumor in former and current smokers, ACTC1, MYH2, DES,
MYBPH, MYLPF were the top 5 most down-regulated genes. Mean-
while, CYP2W1, FAIM2, OLFML1, KRT13 were found to be up-regu-
lated when comparing differential gene expression between these
groups (fold change > 8). Despite prolonged smoking cessation, some
gene expression could appear to be permanently altered and these
irreversible changes may account for oral cancer risk despite smok-
ing cessation.
Conclusion: These ﬁndings illustrate the potential for next gen-
eration sequencing to provide insights into the unique gene expres-
sion proﬁles associated with risk habits which will be useful in
developing biomarkers for prognostic and therapeutic applications
in the future.
doi:10.1016/j.oraloncology.2011.06.169
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